Cargando…

Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease

Parkinson’s disease (PD) is the second most common age-related neurodegenerative disorder. The neurodegeneration leading to incapacitating motor abnormalities mainly occurs in the nigrostriatal pathway due to the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Several anim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barata-Antunes, Sandra, Teixeira, Fábio G., Mendes-Pinheiro, Bárbara, Domingues, Ana V., Vilaça-Faria, Helena, Marote, Ana, Silva, Deolinda, Sousa, Rui A., Salgado, António J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279033/ https://www.ncbi.nlm.nih.gov/pubmed/32422916 http://dx.doi.org/10.3390/ijms21103459

Ejemplares similares

Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson’s Disease
por: Teixeira, Fábio G., et al.
Publicado: (2020)

MSCs-Derived Exosomes: Cell-Secreted Nanovesicles with Regenerative Potential
por: Marote, Ana, et al.
Publicado: (2016)

Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
por: Mendes-Pinheiro, Bárbara, et al.
Publicado: (2019)

Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response
por: Mendes-Pinheiro, Bárbara, et al.
Publicado: (2021)

Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s Disease?
por: Vilaça-Faria, Helena, et al.
Publicado: (2019)

Treating Parkinson’s Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration
por: Mendes-Pinheiro, Bárbara, et al.
Publicado: (2023)

Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson’s Disease Induced by 6-OHDA
por: Gomes, Felipe Azevedo, et al.
Publicado: (2019)

Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone
por: Rodrigues, Laís D., et al.
Publicado: (2019)

Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I, et al.
Publicado: (2015)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson’s Disease
por: Shah, Anuri, et al.
Publicado: (2019)

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
por: Tu, Li, et al.
Publicado: (2019)

Behavioral and Neurochemical Effects of Alpha-Lipoic Acid in the Model of Parkinson's Disease Induced by Unilateral Stereotaxic Injection of 6-Ohda in Rat
por: de Araújo, Dayane Pessoa, et al.
Publicado: (2013)

Erratum to: Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I., et al.
Publicado: (2015)

6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson's Disease
por: Murillo, Maria Del Pilar, et al.
Publicado: (2023)

Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
por: Rees, Daniel, et al.
Publicado: (2022)

Propolis as a Potential Disease-Modifying Strategy in Parkinson’s disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model
por: C. Gonçalves, Valeria, et al.
Publicado: (2020)

From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson's disease?
por: Silva, Rita Caridade, et al.
Publicado: (2021)

Fraternine, a Novel Wasp Peptide, Protects against Motor Impairments in 6-OHDA Model of Parkinsonism
por: Biolchi, Andréia Mayer, et al.
Publicado: (2020)

Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease
por: Teixeira, Fábio G., et al.
Publicado: (2016)

Identification of Bilateral Changes in TID1 Expression in the 6-OHDA Rat Model of Parkinson's Disease
por: Proft, Juliane, et al.
Publicado: (2011)

Dopamine Transporter Loss in 6-OHDA Parkinson’s Model Is Unmet by Parallel Reduction in Dopamine Uptake
por: Chotibut, Tanya, et al.
Publicado: (2012)

Cell Fate Analysis of Embryonic Ventral Mesencephalic Grafts in the 6-OHDA Model of Parkinson's Disease
por: Neto, Sonya Carvalho, et al.
Publicado: (2012)

Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson's disease model
por: Shalavadi, M. H., et al.
Publicado: (2012)

Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease
por: Boronat-García, Alejandra, et al.
Publicado: (2016)

Gait Analysis for Early Detection of Motor Symptoms in the 6-OHDA Rat Model of Parkinson's Disease
por: Boix, Jordi, et al.
Publicado: (2018)

Botulinum Toxin A Ameliorates Neuroinflammation in the MPTP and 6-OHDA-Induced Parkinson’s Disease Models
por: Ham, Hyeon Joo, et al.
Publicado: (2022)

The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson’s Disease Model
por: Jia, Ruru, et al.
Publicado: (2023)

Abscisic acid ameliorates motor disabilities in 6-OHDA-induced mice model of Parkinson's disease
por: Shabani, Mohammad, et al.
Publicado: (2023)

Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease
por: Mendes‐Pinheiro, Bárbara, et al.
Publicado: (2018)

Gastric Helicobacter suis Infection Partially Protects against Neurotoxicity in A 6-OHDA Parkinson’s Disease Mouse Model
por: Berlamont, Helena, et al.
Publicado: (2021)

T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson’s Disease
por: Wheeler, Christopher J, et al.
Publicado: (2014)

Protective effect of methanolic extract of Garcinia indica fruits in 6-OHDA rat model of Parkinson's disease
por: Antala, Bhaveshkumar V., et al.
Publicado: (2012)

Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
por: Perlbarg, Vincent, et al.
Publicado: (2018)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease
por: Voronin, Mikhail V., et al.
Publicado: (2019)

Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease
por: Su, Hui-Chen, et al.
Publicado: (2023)

Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson’s Disease in Rats
por: Tiwari, Prafulla Chandra, et al.
Publicado: (2021)

Exosome Circuitry During (De)(Re)Myelination of the Central Nervous System
por: Domingues, Helena S., et al.
Publicado: (2020)

Mild Prenatal Stress Causes Emotional and Brain Structural Modifications in Rats of Both Sexes
por: Soares-Cunha, Carina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q8a11hti8ccjhp7ih4882n1j0u